LuciBelu 200mg (Belumosudil)

Description

LuciBelu 200mg (Belumosudil) is a targeted therapy used to treat chronic graft-versus-host disease (cGVHD) in patients who have already received other treatments without sufficient improvement. It works by inhibiting ROCK2 (Rho-associated coiled-coil kinase 2), helping reduce inflammation and immune system overactivity associated with cGVHD.

Dosage:
The usual recommended dose of LuciBelu 200mg (Belumosudil) is 200 mg taken once daily, with food, or as prescribed by a healthcare professional. Treatment generally continues as long as the condition responds and side effects remain manageable.

Side Effects

Some patients using LuciBelu 200mg (Belumosudil) may experience:

• Fatigue
• Diarrhea
• Nausea
• Cough
• Upper respiratory infections

In some cases, LuciBelu 200mg may cause liver enzyme changes or infections, so regular medical monitoring is recommended during treatment.

Prescribing Information

Before starting treatment, patients should be evaluated for chronic graft-versus-host disease and prior therapy history. LuciBelu 200mg (Belumosudil) should be used under the supervision of a qualified healthcare professional experienced in managing cGVHD.

Patients should inform their doctor about all medications they are taking and avoid using LuciBelu 200mg during pregnancy or breastfeeding unless advised by a doctor.

Suggestion

For best results, take LuciBelu 200mg (Belumosudil) exactly as prescribed. Do not change the dosage or stop treatment without consulting your doctor. Regular follow-ups and blood tests may be required during treatment.

FAQ

Why is LuciBelu 200mg prescribed for cGVHD?
LuciBelu 200mg (Belumosudil) helps control immune system activity that causes inflammation and tissue damage in chronic graft-versus-host disease.

What should I do if other treatments for cGVHD have not worked?
Doctors may prescribe LuciBelu 200mg as an option for patients who have already tried other therapies but still have symptoms.

How long does treatment with LuciBelu 200mg usually continue?
Treatment typically continues as long as the medicine is helping control symptoms and side effects remain manageable.